Press release
Artificial Intelligence in Diagnostics Market to Reach USD 10.84 Billion by 2030
Artificial Intelligence in Diagnostics Market
Introduction
The Artificial Intelligence in Diagnostics Market is undergoing significant transformation as healthcare systems worldwide adopt AI-powered tools to improve diagnostic accuracy, reduce workloads, speed up clinical decision-making, and facilitate personalized medicine.
AI-enabled diagnostics are revolutionizing:
• Radiology (CT, MRI, X-ray, Ultrasound)
• Digital Pathology
• Cardiology imaging
• Cancer screening platforms
• Genomic diagnostics
• Clinical decision support systems (CDSS)
• Point-of-care AI tools
• Population-health analytics
As hospitals face rising imaging volumes and staff shortages, AI has become a critical component in strengthening diagnostic capabilities.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73671
Key Takeaways
• Market Size (2023): USD 3.42 Billion
• Market Size (2030): USD 10.84 Billion
• CAGR (2024-2030): 17.6%
• AI adoption in radiology exceeds 62% across major hospitals as of 2024.
• Top players include GE HealthCare, Siemens Healthineers, Philips, IBM Watson Health, Google Health, Canon Medical, Fujifilm, NVIDIA, Arterys, Aidoc, Paige AI, and HeartFlow.
• Strongest demand comes from oncology, cardiology, neurology, and infectious disease diagnostics.
Market Story
AI is transforming diagnostics by improving accuracy, enabling earlier disease detection, and reducing clinical workflow bottlenecks.
1. Radiology Leads Global AI Adoption
AI is enhancing:
• Automated detection of tumors, lesions & anomalies
• Real-time imaging triage
• Reconstruction algorithms for faster scans
• Reduction of diagnostic errors
Radiology accounts for 48% of total AI-diagnostics revenue.
2. Digital Pathology & Cancer Diagnostics Surge
AI supports:
• Whole-slide image (WSI) interpretation
• Tumor grading & biomarker quantification
• Immunohistochemistry (IHC) scoring automation
• Molecular pathology decision support
AI-driven pathology reduces analysis time by 30-50%.
3. Cardiology Diagnostics Accelerate
Key applications:
• AI-enabled ECG interpretation
• Coronary CT angiography analytics
• Heart failure prediction models
• Automated ejection-fraction measurements
Platforms like HeartFlow AI are transforming non-invasive cardiac diagnostics.
4. Genomic & Precision Medicine AI Adoption Grows
AI tools support:
• Variant calling
• Polygenic risk scoring
• Disease-risk prediction
• Pharmacogenomic analysis
• Rare-disease identification
This segment is growing at >20% CAGR.
5. AI-Driven Clinical Decision Support (CDSS) Expands
Hospitals are adopting AI for:
• Early sepsis alerts
• Antibiotic stewardship
• Risk stratification models
• Predictive analytics for ICU & ER
CDSS improves care quality and reduces clinician burnout.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73671/artificial-intelligence-in-diagnostics-market
Market Segments
By Component
• Software Solutions (largest segment)
• AI Platforms
• Services & Integration
• Hardware (GPU, edge devices)
By Diagnostic Type
• Medical Imaging Diagnostics
• Digital Pathology Diagnostics
• Genomic Diagnostics
• Cardiology Diagnostics
• Neurology Diagnostics
• Respiratory Disease Diagnostics
• Infectious Disease Diagnostics
By Modality
• CT Scan
• MRI
• X-Ray
• Ultrasound
• PET/CT
• Digital Pathology WSI
By End User
• Hospitals & Diagnostic Centers
• Research & Academic Institutes
• Digital Health Companies
• Clinical Laboratories
By Region
• North America - largest market
• Europe - strong adoption in cancer screening
• Asia-Pacific - highest CAGR
• Latin America
• Middle East & Africa
Recent Developments
• GE HealthCare launched new AI-assisted CT & MRI diagnostic models.
• Siemens Healthineers integrated AI-Rad Companion across imaging portfolio.
• Philips expanded AI-based oncology and cardiology diagnostic platforms.
• Google Health advanced breast-cancer AI screening tools.
• NVIDIA + GE + Siemens expanded collaborative medical-AI ecosystems.
• Paige AI gained approvals for digital AI-pathology tools in cancer care.
• Aidoc expanded AI-triage tools to stroke & cardiac emergencies.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73671
Expert Quote
"AI in diagnostics is reshaping healthcare delivery by enabling earlier detection, faster workflows, and unprecedented accuracy. From radiology to genomics, AI is now central to high-performance diagnostic systems worldwide."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Market Drivers
• Rising imaging volumes and global radiologist shortages
• Increased demand for precision diagnostics
• Advances in GPU/edge computing for real-time analysis
• Expansion of hospital digital-transformation roadmaps
• Growing use of AI in cancer screening & cardiology
• Supportive regulatory frameworks (FDA, CE certifications)
Forecast Outlook
The AI in Diagnostics market will surpass USD 10.84 billion by 2030, driven by:
• Multi-modal AI platforms combining imaging + genomics
• Cloud-based diagnostic intelligence
• AI-enabled triage for emergency medicine
• Full-scale digital pathology adoption
• Smart hospital ecosystems with predictive tools
Regional Highlights
• U.S.: Fastest AI approvals and advanced integration
• Europe: Strong cancer-diagnostics initiatives
• China, India & Japan: Rapid digital-health expansion
• Middle East: AI-driven smart-hospital investments
Government & Regulatory Initiatives
• FDA approvals for AI-enabled imaging tools
• EU AI Act shaping medical-AI compliance
• National cancer-screening AI programs
• Government digital-health missions (India, China, UAE)
• Grants supporting AI-in-healthcare R&D worldwide
Conclusion
AI is transforming diagnostics into a faster, more accurate, and more predictive ecosystem. Hospitals, digital-health companies, and diagnostic labs adopting AI will lead the future of precision medicine.
This report is also available in the following languages : Japanese (診断市場における人工知能), Korean (진단 시장의 인공지능), Chinese (人工智能在诊断市场的应用), French (Marché de l'intelligence artificielle dans le diagnostic), German (Markt für künstliche Intelligenz in der Diagnostik), and Italian (Intelligenza artificiale nel mercato della diagnostica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73671
Our More Reports:
M&A Trends in Pharma, Q2 2025 Market
https://exactitudeconsultancy.com/reports/73663/m-a-trends-in-pharma-q2-2025-market
New Drug Approvals and Their Contract Manufacture Market
https://exactitudeconsultancy.com/reports/73665/new-drug-approvals-and-their-contract-manufacture-market
Emerging Market
https://exactitudeconsultancy.com/reports/73667/emerging-market
AI in Drug Manufacturing Market
https://exactitudeconsultancy.com/reports/73669/ai-in-drug-manufacturing-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence in Diagnostics Market to Reach USD 10.84 Billion by 2030 here
News-ID: 4295401 • Views: …
More Releases from Exactitude Consultancy
Electronic Batch Records (EBR) Market to Reach USD 3.96 Billion by 2030
Sub-Headline: The global Electronic Batch Records (EBR) Market is set to grow from USD 1.82 billion in 2023 to USD 3.96 billion by 2030, at a strong CAGR of 11.4%, driven by rising GMP compliance needs, digital transformation across pharmaceutical manufacturing, and growing adoption of MES-integrated paperless batch execution.
Introduction
The Electronic Batch Records (EBR) Market is rapidly expanding as pharmaceutical, biotech, API, and CDMO/CMO manufacturers transition from manual, paper-based batch documentation…
AI in Drug Manufacturing Market to Reach USD 6.94 Billion by 2030 as Pharma Digi …
Sub-Headline: The global AI in Drug Manufacturing Market is projected to grow from USD 2.41 billion in 2023 to USD 6.94 billion by 2030, registering a powerful CAGR of 16.5%, driven by rapid automation, digital twins, real-time quality analytics, and AI-driven bioprocess optimization across global GMP facilities.
Introduction
The AI in Drug Manufacturing Market is undergoing a major digital transformation as pharmaceutical companies accelerate adoption of artificial intelligence, machine learning, predictive analytics,…
Emerging Pharma & Healthcare Markets to Reach USD 1.72 Trillion by 2030 as Asia- …
Sub-Headline: The Emerging Pharma & Healthcare Market across Asia-Pacific, Latin America, Middle East, Africa, and Eastern Europe is projected to grow from USD 982 billion in 2023 to USD 1.72 trillion by 2030, registering a strong CAGR of 8.3%, driven by rising healthcare spending, rapid regulatory modernization, booming generics & biologics production, and digital-health adoption.
Introduction
The Emerging Pharma & Healthcare Market is entering a high-growth decade as countries across Asia-Pacific, LATAM,…
New Drug Approvals & Contract Manufacturing Market to Reach USD 87.3 Billion by …
Sub-Headline: The global market for newly approved drugs and their contract manufacturing services is projected to grow from USD 54.6 billion in 2023 to USD 87.3 billion by 2030, reflecting a strong CAGR of 7.0%, driven by rapid approvals of biologics, antibody-drug conjugates (ADCs), mRNA vaccines, cell & gene therapies, and the rising outsourcing needs of pharmaceutical innovators.
Introduction
The New Drug Approvals and Their Contract Manufacture Market is entering a high-growth…
More Releases for Diagnostic
Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804
This latest report researches the industry structure, sales, revenue,…
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688
This latest report researches the industry structure, sales, revenue,…
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of…
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects.
Tenet Diagnostics got its NABL certification in the fastest time and is…
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends…
